Table 3.
Comparison of blood parameters.
| Baseline | M post | LA post | |
|---|---|---|---|
| Glucose (mg/dl) | 88.5 ± 5.0 | 86.1 ± 6.1 | 96.1 ± 6.0 |
| Insulin (μU/mL) | 24.0 ± 4.7 | 19.1 ± 2.8 | 22.1 ± 5.6 |
| TG (mg/dl) | 129.8 ± 7.9 | 123.9 ± 15.1 | 96.2 ± 13.5 |
| HDL-C (mg/dl) | 53.9 ± 3.1 | 60.0 ± 3.8 | 60.9 ± 4.9 |
| LDL-C (mg/dl) | 89.9 ± 6.7 | 87.4 ± 6.8 | 86.1 ± 6.2 |
| ApoA1 (mg/dl) | 142.2 ± 6.9 | 150.3 ± 8.4 | 146.9 ± 8.1 |
| ApoB (mg/dl) | 69.9 ± 3.9 | 67.3 ± 4.3 | 67.5 ± 4.5 |
| ApoB/ApoA1 | 0.51 ± 0.04 | 0.47 ± 0.04 | 0.48 ± 0.05 |
| CUC (unit/ml) | 99.9 ± 6.2 | 116.7 ± 11.5 | 113.1 ± 10.6 |
All data are presented as mean ± standard error, TG: triglycerides, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, ApoA1: apolipoprotein A1, ApoB: apolipoprotein B, CUC: cholesterol uptake capacity, M post: After the intervention of morning trial, LA post: After the intervention of late afternoon trial. Venous blood samples were collected at baseline and after each trial. The participants were required to abstain from any intense exercise for at least one day before the collection of the blood sample and fast for at least 10 h overnight. The blood samples were collected at 09:00–10:00, and blood samples after each trial intervention were drawn at least 48 h after the end of the last trial.